Document is current
Any future updates will be listed below
-
Authors
Sharma, Ashish https://orcid.org/0000-0002-8550-9791
Parachuri, Nikulaa
Kumar, Nilesh https://orcid.org/0000-0002-7439-2081
Bandello, Francesco https://orcid.org/0000-0003-3238-9682
Kuppermann, Baruch D.
Loewenstein, Anat
Regillo, Carl D.
Chakravarthy, Usha https://orcid.org/0000-0002-2606-3734
- License Information
-
More Information
Article History
Received: 1 February 2021
Revised: 10 March 2021
Accepted: 12 March 2021
First Online: 21 March 2021
Declarations
:
: Dr. Ashish Sharma: CONSULTANT: for Novartis, Allergan, Bayer and Intas. Dr. Francesco Bandello: CONSULTANT: Allergan, Bayer, Boehringer- Ingelheim, FidiaSooft, Hofmann La Roche, Novartis, NTC Pharma, Sifi, Thrombogenics, Zeiss. Baruch D Kuppermann: CLINICAL RESEARCH: Alcon, Alimera, Allegro, Allergan, Apellis, Clearside, Genentech, GSK, Ionis, jCyte, Novartis, Regeneron, ThromboGenics; CONSULTANT: Alimera, Allegro, Allergan, Cell Care, Dose, Eyedaptic, Galimedix, Genentech, Glaukos, Interface Biologics, jCyte, Novartis, Ophthotech, Regeneron, Revana, Theravance Biopharma. Dr. Anat Loewenstein reports other from Allergan, other from Novartis, other from Roche, other from Notal Vision, other from Forsightslabs, other from Beyeonics, other from Bayer Health Care. Dr. Carl D Regillo: CONSULTANT: Allergan, Chengdu Kanghong, Genentech/Roche, Novartis, Kodiak, Notal, Merck, Shire-Takeda, Adverum, Graybug, and Eyepoint and receives research support from Allergan, Chengdu Kanghong, Genentech/Roche, Novartis, Kodiak, Iveric, and Adverum. Dr. Usha Chakravarthy: personal fees from Allergan, Bayer, Novartis, and Roche; and is a data safety and monitoring board member for Bayer. Dr. Nileah Kumar: None. Dr. Nikulaa Parachuri: None
Free to read: This content has been made available to all.
